Cargando…

Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches

Estrogen receptor α (ERα) is a successful target for ER-positive breast cancer and also reported to be relevant in many other diseases. Selective estrogen receptor modulators (SERMs) make a good therapeutic effect in clinic. Because of the drug resistance and side effects of current SERMs, the disco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Xiaocong, Fu, Weiqi, Wang, Jinhua, Kang, De, Xu, Lvjie, Zhao, Ying, Liu, Ai-Lin, Du, Guan-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971309/ https://www.ncbi.nlm.nih.gov/pubmed/29861831 http://dx.doi.org/10.1155/2018/6040149

Ejemplares similares

The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease
por: Pang, Xiaocong, et al.
Publicado: (2017)

Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches
por: Kang, De, et al.
Publicado: (2018)

In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L
por: Cai, Chuipu, et al.
Publicado: (2021)

Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2019)

Estrogen Antagonist and Development of Macular Hole
por: Chung, Song Ee, et al.
Publicado: (2010)

Identification of potential TNF-α inhibitors: from in silico to in vitro studies
por: Zia, Komal, et al.
Publicado: (2020)

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome
por: Fang, Jiansong, et al.
Publicado: (2021)

The Natural Estrogenic Compound Diarylheptanoid (D3): In Vitro Mechanisms of Action and in Vivo Uterine Responses via Estrogen Receptor α
por: Winuthayanon, Wipawee, et al.
Publicado: (2013)

Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches
por: Pang, Xiaocong, et al.
Publicado: (2018)

INDUCTION OF ENDOMETRIAL PEROXIDASE SYNTHESIS AND SECRETION BY ESTROGEN AND ESTROGEN ANTAGONIST
por: Churg, Andrew, et al.
Publicado: (1974)

Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach
por: Puranik, Ninad V., et al.
Publicado: (2019)

Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists
por: Ng, Hui Wen, et al.
Publicado: (2014)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

In silico docking and ADME study of deketene curcumin derivatives (DKC) as an aromatase inhibitor or antagonist to the estrogen-alpha positive receptor (Erα(+)): potent application of breast cancer
por: Shah, Vraj, et al.
Publicado: (2022)

DL0410 Ameliorates Memory and Cognitive Impairments Induced by Scopolamine via Increasing Cholinergic Neurotransmission in Mice
por: Lian, Wenwen, et al.
Publicado: (2017)

In Silico, In Vitro, and In Vivo Evaluation of the Developmental Toxicity, Estrogenic Activity, and Mutagenicity of Four Natural Phenolic Flavonoids at Low Exposure Levels
por: Zhang, Xinwen, et al.
Publicado: (2022)

Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening
por: Wang, Xing, et al.
Publicado: (2016)

In silico estrogen receptor alpha antagonist studies and toxicity prediction of Melia azedarach leaves bioactive ethyl acetate fraction
por: Ervina, Martha, et al.
Publicado: (2021)

In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
por: Puls, Kristina, et al.
Publicado: (2022)

MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
por: Lappano, Rosamaria, et al.
Publicado: (2012)

In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
por: Herrmann, Fabian C., et al.
Publicado: (2017)

Estrogen Receptor α Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt Antagonist Sost Is Mediated by Estrogen Receptor β
por: Galea, Gabriel L., et al.
Publicado: (2013)

Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer’s Disease Agents Using Pharmacophore, 3D-QSAR and Molecular Docking Approaches
por: Pang, Xiaocong, et al.
Publicado: (2017)

Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent
por: Pang, Xiaocong, et al.
Publicado: (2017)

Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual-acting cholinesterase inhibitor and histamine-3 receptor antagonist
por: Pang, Xiaocong, et al.
Publicado: (2019)

Identification of Oleanolic Acid as Allosteric Agonist of Integrin α(M) by Combination of In Silico Modeling and In Vitro Analysis
por: Jin, Lu, et al.
Publicado: (2021)

Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra)
por: Simons, Rudy, et al.
Publicado: (2011)

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
por: Montoya, Marhiah C., et al.
Publicado: (2018)

In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase †
por: Herrmann, Fabian C., et al.
Publicado: (2015)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

A Systematic In Silico Mining of the Mechanistic Implications and Therapeutic Potentials of Estrogen Receptor (ER)-α in Breast Cancer
por: Li, Xin, et al.
Publicado: (2014)

Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
por: Mao, XiaoDan, et al.
Publicado: (2019)

Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ
por: Matsushima, Ayami, et al.
Publicado: (2010)

From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target
por: Mottamal, Madhusoodanan, et al.
Publicado: (2021)

Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogenic compounds.
por: Lascombe, I, et al.
Publicado: (2000)

In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library
por: Shahhamzehei, Nasim, et al.
Publicado: (2022)

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance
por: Ma, Yongxian, et al.
Publicado: (2015)

G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer
por: Liu, Changyu, et al.
Publicado: (2019)

Alternaria toxins as casein kinase 2 inhibitors and possible consequences for estrogenicity: a hybrid in silico/in vitro study
por: Aichinger, Georg, et al.
Publicado: (2020)

Estrogenic Activity of Mycoestrogen (3β,5α,22E)-Ergost-22-en-3-ol via Estrogen Receptor α-Dependent Signaling Pathways in MCF-7 Cells
por: Lee, Dahae, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gs3ulr45qndb8mfh2psan3228r